← FDA DRUG APPROVALS
FDA ANDA · ANDA040466
DIPHENHYDRAMINE
diphenhydramine hydrochloride
Sponsor: APP PHARMS
APPLICATION
ANDA040466
TYPE
ANDA
ORIGINAL APPROVAL
2002-05-28
LATEST ACTION
2002-05-28
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
DIPHENHYDRAMINE HYDROCHLORIDEPrescription
DIPHENHYDRAMINE HYDROCHLORIDE 50MG/ML · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.